久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Rafael Expands CPI-613 Trial americanpharmaceuticalreview
    December 27, 2019
    Rafael Pharmaceuticals announced the expansion of its Phase 2 clinical trial of CPI-613? (devimistat) for patients with relapsed or refractory Burkitt’s lymphoma/leukemia.
PharmaSources Customer Service